← Back to Screener
KORU Medical Systems, Inc. Common Stock (DE) (KRMD)
Price$4.26
Favorite Metrics
Price vs S&P 500 (26W)-7.81%
Price vs S&P 500 (4W)-6.64%
Market Capitalization$200.78M
All Metrics
P/CF (Annual)434.21x
Book Value / Share (Quarterly)$0.37
P/TBV (Annual)16.45x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)13.81%
Cash Flow / Share (Quarterly)$-0.01
Price vs S&P 500 (YTD)-29.61%
Gross Margin (TTM)62.26%
Net Profit Margin (TTM)-6.41%
EPS (TTM)$-0.06
10-Day Avg Trading Volume0.17M
EPS Excl Extra (TTM)$-0.06
Revenue Growth (5Y)11.21%
EPS (Annual)$-0.06
ROI (Annual)-15.29%
Gross Margin (Annual)62.26%
Net Profit Margin (5Y Avg)-24.61%
Cash / Share (Quarterly)$0.19
Revenue Growth QoQ (YoY)23.27%
ROA (Last FY)-9.35%
Revenue Growth TTM (YoY)22.23%
EBITD / Share (TTM)$-0.05
ROE (5Y Avg)-31.84%
Operating Margin (TTM)-7.23%
Cash Flow / Share (Annual)$-0.01
P/B Ratio11.78x
P/B Ratio (Quarterly)15.79x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)4.67x
Net Interest Coverage (TTM)-317.00x
ROA (TTM)-9.77%
EV / EBITDA (TTM)1280.77x
EPS Incl Extra (Annual)$-0.06
Current Ratio (Annual)2.44x
Quick Ratio (Quarterly)1.88x
3-Month Avg Trading Volume0.18M
52-Week Price Return89.08%
Revenue / Employee (TTM)$1
Tangible BV / Share (Quarterly)$0.35
P/S Ratio (Annual)4.88x
Asset Turnover (Annual)1.46x
52-Week High$6.61
Operating Margin (5Y Avg)-26.19%
EPS Excl Extra (Annual)$-0.06
CapEx CAGR (5Y)-2.03%
Tangible BV CAGR (5Y)-14.26%
26-Week Price Return0.93%
Quick Ratio (Annual)1.88x
13-Week Price Return-22.26%
Total Debt / Equity (Annual)0.01x
Current Ratio (Quarterly)2.44x
Enterprise Value$192.115
Revenue / Share Growth (5Y)9.08%
Asset Turnover (TTM)1.52x
Book Value / Share Growth (5Y)-15.15%
Revenue / Employee (Annual)$1
Inventory Turnover (Annual)4.79x
Pretax Margin (Annual)-6.36%
Cash / Share (Annual)$0.19
3-Month Return Std Dev41.61%
Gross Margin (5Y Avg)59.59%
Net Income / Employee (TTM)$-0
ROE (Last FY)-15.47%
Net Interest Coverage (Annual)-189.80x
EPS Basic Excl Extra (Annual)$-0.06
P/FCF (TTM)295.54x
Receivables Turnover (TTM)6.89x
Total Debt / Equity (Quarterly)0.01x
EPS Incl Extra (TTM)$-0.06
Receivables Turnover (Annual)6.89x
ROI (TTM)-15.55%
P/S Ratio (TTM)4.88x
Pretax Margin (5Y Avg)-24.80%
Revenue / Share (Annual)$0.89
Tangible BV / Share (Annual)$0.35
Price vs S&P 500 (52W)53.99%
Year-to-Date Return-25.47%
5-Day Price Return-0.23%
EPS Normalized (Annual)$-0.06
ROA (5Y Avg)-22.28%
Net Profit Margin (Annual)-6.41%
Month-to-Date Return0.23%
Cash Flow / Share (TTM)$-0.17
EBITD / Share (Annual)$-0.05
Operating Margin (Annual)-7.23%
LT Debt / Equity (Annual)0.00x
P/CF (TTM)434.21x
ROI (5Y Avg)-30.89%
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-0.06
P/TBV (Quarterly)16.45x
P/B Ratio (Annual)15.79x
Inventory Turnover (TTM)4.79x
Pretax Margin (TTM)-6.36%
Book Value / Share (Annual)$0.37
Price vs S&P 500 (13W)-25.13%
Beta0.49x
P/FCF (Annual)200.78x
Revenue / Share (TTM)$0.89
ROE (TTM)-15.89%
52-Week Low$2.08
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.00
4.00
4.00
4.00
Industry Peers — Surgical & Medical Instruments(108)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
KRMDKORU Medical Systems, Inc. Common Stock (DE) | 4.88x | 11.21% | 62.26% | -7.23% | $4.26 |
SYKStryker Corporation | 5.17x | 11.84% | 64.57% | 19.43% | $338.34 |
BSXBoston Scientific Corp. | 4.58x | 15.16% | 69.01% | 18.00% | $60.99 |
MMM3M Company | 3.21x | -4.97% | 39.92% | 18.55% | $151.40 |
MDLNMedline Inc. Class A common stock | 2.20x | — | 26.44% | 7.78% | $48.26 |
BDXBecton, Dickinson and Co. | 2.06x | 6.32% | 46.42% | 12.15% | $158.64 |
RMDResMed Inc. | 6.07x | 11.72% | 60.85% | 33.70% | $226.14 |
DXCMDexCom, Inc. | 5.33x | 19.33% | 62.09% | 19.56% | $64.62 |
WSTWest Pharmaceutical Services, Inc. | 6.29x | 7.44% | 35.91% | 19.03% | $278.00 |
PODDInsulet Corporation | 5.19x | 24.53% | 71.63% | 12.92% | $200.87 |
PENPenumbra, Inc. | 9.24x | 20.16% | 67.14% | 13.48% | $329.71 |
About
KORU Medical Systems develops and manufactures subcutaneous infusion devices designed to deliver immunoglobulin therapies for patients with primary immunodeficiencies and chronic inflammatory demyelinating polyneuropathy. The company's flagship FREEDOM Infusion System product line includes the FREEDOM60 and FreedomEdge syringe drivers along with complementary delivery components. KORU serves the home and clinical infusion therapy market for chronic immunological disorders.